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Abstract
The Guinea-Bissau family of strains is a unique group of the Mycobacterium tuberculosis complex that, although
genotypically closely related, phenotypically demonstrates considerable heterogeneity. We have investigated 414 M.
tuberculosis complex strains collected in Guinea-Bissau between 1989 and 2008 in order to further characterize the Guinea-
Bissau family of strains. To determine the strain lineages present in the study sample, binary outcomes of spoligotyping
were compared with spoligotypes existing in the international database SITVIT2. The major circulating M. tuberculosis clades
ranked in the following order: AFRI (n=195, 47.10%), Latin-American-Mediterranean (LAM) (n=75, 18.12%), ill-defined T
clade (n=53, 12.8%), Haarlem (n=37, 8.85%), East-African-Indian (EAI) (n=25, 6.04%), Unknown (n=12, 2.87%), Beijing
(n=7, 1.68%), X clade (n=4, 0.96%), Manu (n=4, 0.97%), CAS (n=2, 0.48%). Two strains of the LAM clade isolated in 2007
belonged to the Cameroon family (SIT61). All AFRI isolates except one belonged to the Guinea-Bissau family, i.e. they have
an AFRI_1 spoligotype pattern, they have a distinct RFLP pattern with low numbers of IS6110 insertions, and they lack the
regions of difference RD7, RD8, RD9 and RD10, RD701 and RD702. This profile classifies the Guinea-Bissau family, irrespective
of phenotypic biovar, as part of the M. africanum West African 2 lineage, or the AFRI_1 sublineage according to the
spoligtyping nomenclature. Guinea-Bissau family strains display a variation of biochemical traits classically used to
differentiate M. tuberculosis from M. bovis. Yet, the differential expression of these biochemical traits was not related to any
genes so far investigated (narGHJI and pncA). Guinea-Bissau has the highest prevalence of M. africanum recorded in the
African continent, and the Guinea-Bissau family shows a high phylogeographical specificity for Western Africa, with Guinea-
Bissau being the epicenter. Trends over time however indicate that this family of strains is waning in most parts of Western
Africa, including Guinea-Bissau (p=0.048).
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Introduction
Guinea-Bissau is a West African country with a population of
approximately 1.6 million people. It is a country with one of the
highest tuberculosis (TB) burdens in the world. In previous studies
of Mycobacterium tuberculosis complex isolates from Guinea-Bissau,
we identified a unique group of strains that we designated the
Guinea-Bissau family of strains [1,2]. Based on a genotypic
analysis of a subset of Guinea-Bissau family isolates, and a
comparison of known corresponding genes in mycobacteria
outside the M. tuberculosis complex, we proposed that strains of
the Guinea-Bissau family belong to a unique branch of the M.
tuberculosis complex tree positioned between classical M. tuberculosis
and classical M. bovis [2], clustering together within one of the M.
africanum subtype I branches [3]. The most intriguing fact about
the Guinea-Bissau family of strains is that, although genotypically
closely related, they demonstrate a considerable heterogeneity of
phenotypic traits [1,2], with a variation in niacin production,
pyrazinamide (PZA) resistance, and nitrate reductase activity, that
are basic phenotypic criteria for differentiating M. tuberculosis and
M. bovis. Yet, the differential expression of these biochemical traits
by the Guinea-Bissau family of strains have not been related to any
genes so far investigated [2].
Since the first M. tuberculosis strains from the late 1980s and early
1990s were isolated in Guinea-Bissau [1,4] there has been a war in
the country. This caused the TB program to dissolve, the
Reference TB hospital was out of function and the TB laboratory
at the Laborato ´rio Nacional de Sau ´dePu ´blica (LNSP), Bissau, was
destroyed and no drug resistance surveillance could be performed.
Culture of sputum samples has only recently been made possible
PLoS ONE | www.plosone.org 1 April 2011 | Volume 6 | Issue 4 | e18601again. We have now collected a new sample of M. tuberculosis
complex isolates from patients with pulmonary TB and compared
them to previously collected (published and unpublished) isolates
in terms of genotype. Thus, we hereby reinvestigated M. tuberculosis
complex clinical isolates from Guinea-Bissau (n=414) collected
between 1989 and 2008 with emphasis on the phylogeography, of
the Guinea-Bissau family of strains, and their differential
expression of biochemical traits.
Materials and Methods
Ethics Statement
The Research Committee at Karolinska Institutet exempted this
retrospective study from review because it describes bacterial
samples collected during the course of routine surveillance, and
waived the need for consent due to the fact that the samples
received could only be combined with the sex, age, and country of
birth of the patients from which the strains were isolated.
Patients
The isolates were collected consecutively as part of epidemio-
logical TB studies in Guinea-Bissau. The patients had been
referred to the Raoul Follereau Reference TB hospital in Bissau,
Guinea-Bissau from various part of the country. The Hospital is
the TB National Reference Center, therefore receives patients
from the entire country, namely patients referred from regional
hospitals or health centers and also patients coming by themselves.
Patients come from the entire country (Bissau, Gabu, Bafata,
Cacheu regions).
Study A. During 1989–1994, 229 isolates from the same
number of patients with positive cultures for the M. tuberculosis
complex were collected as part of an epidemiological TB study in
Guinea-Bissau [1,2,4,5,6].
Study B. As part of a survey of drug resistance, a systematic
collection of M. tuberculosis complex isolates was performed
between 1994–1998. Approximately 700 sputum samples from
the same number of patients with suspected pulmonary TB were
collected at the Raoul Follereau Reference TB hospital. Positive
culture for the M. tuberculosis complex was confirmed for 192
samples.
Study C. During 2006, 2007 and 2008 approximately 400
sputum samples from the same number of patients were collected.
Out of these, 85 were culture positive for the M. tuberculosis
complex.
Mycobacterium tuberculosis complex isolates
Isolates included in study A, B and late part of study C were
cultured at the LNSP as previously described [1]. Culture in the
early part of study C was performed at the TB laboratory,
Karolinska University Hospital, Stockholm, Sweden. All M.
tuberculosis complex isolates were transported to the Reference
TB laboratory at the Swedish Institute for Infectious Disease
Control, Solna, Sweden, for further molecular characterization.
Spoligotyping
Spoligotyping relied on the amplification of the polymorphic
direct repeat region [7] to obtain hybridization patterns of the
amplified DNA using multiple synthetic spacer oligonucleotides,
which are covalently bound to a membrane (Isogen Bioscience
BV, The Netherlands).
Database comparison of spoligotypes
Spoligotypes in binary format were entered in the SITVIT2
database (Pasteur Institute of Guadeloupe), which is an updated
version of the previously released SpolDB4 database [8]. Of 414
isolates 229 had been previously entered by us into the database,
and 185 were added in conjunction with this study. At the time of
the present study, SITVIT2 contained genotyping information on
about 75,000 M. tuberculosis clinical isolates from 160 countries of
origin. In this database, SIT (Spoligotype International Type)
designates spoligotypes shared by two or more patient isolates, as
opposed to ‘‘orphan’’ which designates patterns reported for a
single isolate. Major phylogenetic clades were assigned according
to signatures provided in SpolDB4, which defined 62 genetic
lineages/sub-lineages. These include specific signatures for various
M. tuberculosis complex species such as M. bovis, M. microti, M. caprae,
M. pinipedii, and M. africanum, as well as rules defining major
lineages/sublineages for M. tuberculosis sensu stricto. These include
the Beijing clade, the Central Asian (CAS) clade and two
sublineages, the East African-Indian (EAI) clade and nine
sublineages, the Haarlem (H) clade and three sublineages, the
Latin American-Mediterranean (LAM) clade and 12 sublineages,
the ‘‘Manu’’ family and three sublineages, the S clade, the
IS6110–low-banding X clade and four sublineages, and an ill-
defined T clade with five sublineages.
IS6110 RFLP analyses
A standardized method for IS6110 RFLP analysis [9] was used.
DNA was extracted and RFLP typing was performed using the
insertion sequence IS6110 as a probe and PvuII as the restriction
enzyme. Visual bands were analyzed using the BioNumerics
software version 5.10 (Applied Maths, Kortrijk, Belgium).
Fingerprint patterns were compared by the un-weighted pair-
group method of arithmetic averaging using the Jaccard
coefficient. Dendrograms were constructed to show the degree of
relatedness among strains according to a previously described
algorithm [10], and similarity matrixes were generated to visualize
the relatedness between the banding patterns of all isolates.
PCR for RD702
Genomic DNA (10–20 ng) for RD702, which delineates the
branch of M. africanum West African 2 lineage [11,12] was
amplified in a volume of 25 mL, which contained premixed Taq, Q
solution (both from Qiagen), and primers RD702F (TTCCGAG-
GACCCGTTGTTGAGTGC) and RD702R (GGGCGGGT-
TGGGTTGCTGGTC) at a final concentration of 0.2 mmol/L
[3,11]. Conditions used for the amplification were as follows: 94uC
for 3 min, followed by 35 cycles each of 94uC for 1 min, 64uC for
1 min, and 72uC for 1 min. PCR products of , 2 kb for the
control strain H37Rv and , 700 bp for the isolates belonging to
M. africanum West African 2 lineage were visualized on a 0.8%
agarose gel [12].
Single-nucleotide polymorphism in the narGHJI operon
A mutation in the narGHJI operon has been reported to be
responsible for differential nitrate reductase activity of M.
tuberculosis (-215T) versus M. bovis (-215C) [13]. The single-
nucleotide polymorphism (SNP) at position -215 within the nitrate
reductase (narGHJI) operon promoter in M. tuberculosis complex
isolates with different NO3 activity was investigated. The isolates
were characterized by PCR-RFLP using the previously published
primers LC66 (AACCGACGGTGTGGTTGAC) and LC67
(ATCTCGATGGATGGGCGTC) [13]. The PCR products
obtained were digested using the restriction endonuclease Sau3AI
(Roche-Biomedicals, Meylan, France). This enzyme specifically
cuts at the GATC sequence overlapping the M. bovis-like -215C
narGHJI promoter site, producing two bands in PCR-RFLP of the
LC66-LC67 PCR fragment. In the case of the -215T sequence,
Guinea-Bissau Mycobacterium tuberculosis Complex
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narGHJI amplicon yields a single band.
Geographical distribution of spoligotypes and lineages
The distribution of spoligotypes in the SITVIT2 database, in
relation to their geographical origin was recorded for regions
representing $5% of a given SIT as compared to their total
number in the SITVIT2 database. The various macro-geograph-
ical regions and sub-regions were defined according to the
Table 1. Sublineage distribution and associated SIT
designations for each of the lineages in the study.
Lineage Sublineage SIT
AFRI n=195 (47.10%) AFRI_1 n=194 SIT181 n=96
SIT187 n=46
orphan n=26
SIT536 n=6
SIT188 n=3
SIT318 n=2
SIT326 n=2
SIT525 n=2
SIT530 n=2
SIT532 n=2
SIT3104 n=2
SIT3118* n=2
SIT324 n=1
SIT537 n=1
SIT3130 n=1
AFRI_3 n=1 orphan n=1
LAM n=75 (18.12%) LAM9 n=43 SIT42 n=36
SIT2201 n=2
SIT3020* n=2
SIT766 n=1
SIT866 n=1
orphan n=1
LAM1 n=14 SIT20 n=11
SIT534 n=3
LAM4 n=9 SIT60 n=7
SIT828 n=1
orphan n=1
LAM5 n=3 SIT93 n=1
orphan n=2
LAM2 n=2 SIT604 n=2
LAM3 n=2 SIT4 n=1
SIT3101* n=1
LAM10-CAM n=2 SIT61 n=2
T clade n=53 (12.80%) T1 n=41 SIT53 n=10
SIT244 n=7
SIT334 n=3
SIT804 n=3
orphan n=4
SIT3100* n=3
SIT196 n=2
SIT522 n=2
SIT535 n=2
SIT230 n=1
SIT521 n=1
SIT611 n=1
SIT801 n=1
SIT888 n=1
T n=8 SIT73 n=5
Lineage Sublineage SIT
SIT3129* n=2
SIT2440 n=1
T5 n=3 orphan n=2
SIT44 n=1
T2 n=1 orphan n=1
Haarlem n=37 (8.94%) H1 n=22 SIT47 n=18
SIT62 n=1
SIT531 n=1
SIT2030* n=1
orphan n=1
H3 n=15 SIT50 n=12
SIT533 n=2
SIT75 n=1
EAI n=25 (6.04%) EAI5 n=20 SIT527 n=9
SIT528 n=4
orphan n=4
SIT458 n=2
SIT236 n=1
EAI-SOM n=4 SIT529 n=3
SIT538 n=1
EAI6-BGD n=1 SIT129 n=1
Unknown signatures n=13 (3.14%) Unk n=13 orphan n=6
SIT2445 n=2
SIT3131* n=2
SIT523 n=1
SIT1200 n=1
SIT1204 n=1
Beijing n=7 (1.69%) Beijing n=7 SIT1 n=7
6clade n=4 (0.97%) 63n=2 SIT92 n=2
61n=2 SIT119 n=2
Manu n=4 (0.97%) Manu2 n=2 SIT54 n=1
orphan n=1
Manu1 n=1 SIT3132* n=1
Manu-ancestor n=1 SIT523 n=1
CAS n=2 (0.48%) CAS1-DEL n=2 SIT3111 n=2
Newly-defined SITs are shown by an asterisk while the prototypes defining a
sublineage in SITVIT2 database are shown in bold italics.
doi:10.1371/journal.pone.0018601.t001
Table 1. Cont.
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methods/m49/m49regin.htm). Correlation of spoligotype families
and principal genetic groups (PGG) based on KatG463-gyrA95
polymorphisms [14] was inferred from the reported linking of
specific spoligotype patterns to PGG1 (ancient lineages), and
PGG2/3 (modern lineages) as previously described [8,15,16].
For statistical analysis of trends over time the Chi square test for
trend was performed using PASW v 18.
Results
In study A, spoligotyping and RFLP was performed on 229
isolates. In study B, adequate amounts of DNA, in order to
perform RFLP, were retrieved from 132 isolates, while it was
possible to perform spoligotyping on 138 isolates. In study C,
spoligotyping could be performed on 47 isolates, while sufficient
amounts of DNA were available for RFLP typing of 41 isolates. In
regard to the remaining positive samples they were either too
contaminated or the isolates had died during transportation. All
isolates that were subjected to RFLP were also spoligotyped. For
single-nucleotide polymorphism in the narGHJI operon, 28 isolates
were selected from RFLP cluster B:5 [1] in study A.
Spoligotyping
Altogether, 414 isolates were available for spoligotyping, of
which 336 isolates were grouped into 42 clusters (2–96 isolates per
cluster), accounting for a very high clustering rate of 81.2%, while
the remaining 78 (18. 8%) strains did not cluster. Seven clusters
included more than ten isolates each.
Study A. Out of 229 isolates, 82 different spoligotypes were
obtained, of which 168 (73.4%) were clustered into 21 spoligo-
clusters, comprising 2–61 isolates per cluster. The remaining 61
(26.6%) spoligopatterns were unique i.e. the isolates did not cluster
with other patient isolates. The 229 isolates are identical to those
reported in [1], however a mistake in the recording of one
spoligotype (isolate IH-218) has been corrected here. Also, nine
isolates with unique spoligotypes (summarized in Table 2 of
reference [1]), were not mentioned in the Results section of the
1999 paper.
Study B. Of 138 isolates, 56 different spoligotypes were
obtained, of which 98 (71.0%) were clustered into 15 spoligo-
clusters, comprising 2–26 isolates per cluster. The remaining 40
(29.0%) spoligopatterns were unique i.e. the isolates did not cluster
with other patient isolates.
Study C. Of 47 isolates, 26 different spoligotypes were
obtained, of which 29 (61.7%) were clustered into 8 spoligo-
clusters, comprising 2–9 isolates per cluster. The remaining 18
(38.3%) spoligopatterns were unique i.e. the isolates did not cluster
with other patient isolates.
The spoligotyping results from the SITVIT2 database compar-
ison are summarized in Table 1. Of 120 different patterns for the
414 strains studied 50 patterns corresponded to orphan strains that
were unique among the 75,000 strains recorded in the SITVIT2
database (Supplementary Table S1), as opposed to 70 patterns
corresponding to 364 clinical isolates that corresponded to shared-
types (Supplementary Table S2), i.e. an identical pattern shared
by two or more patients worldwide (within this study, or matching
another strain in the SITVIT2 database). A SIT number was
attributed to each pattern according to the SITVIT2 database.
When the overall repartition of strains according to major M.
tuberculosis genotypic families was defined (Table 1), the major
circulating M. tuberculosis clades ranked in the following order:
AFRI (n=195, 47.10%) . LAM (n=75, 18.12%) . ill-defined T
clade (n=53, 12.80%) . Haarlem (n=37, 8.85%) . EAI (n=25,
6.04%) . Unknown (n=12, 2.87%) . Beijing (n=7, 1.68%) . X
clade (n=4, 0.96%) . Manu (n=4, 0.97%), CAS (n=2, 0.48%).
Two strains of the LAM clade, both isolated in 2007, belonged to
the Cameroon family (SIT61) [17].
The most predominant lineage in Guinea-Bissau was AFRI,
which accounted for as high as 47.10% of all TB cases.
Surprisingly all the cases with AFRI with the exception of a single
orphan isolate classified as AFRI_3, were caused by the AFRI_1
sublineage split into two spoligopatterns – SIT181 (the prototype
of the AFRI_1 sublineage) and SIT187. As compared to the
SITVIT2, these two SITs were highly predominant in Guinea-
Bissau since they alone accounted for 36.92% and 52.87% of all
such strains in the database (414 of 423 isolates from Guinea-
Bissau in the database originating from this study) with extremely
high phylogeographical specificity for Western Africa (74.62 and
74.71% respectively, (Supplementary Table S3).
Another interesting observation was a pattern belonging to the
EAI5 sublineage (SIT527, n=9 strains in this study), with 100% of
the cases being identified so far exclusively in Guinea-Bissau.
These lineages are characteristic of the evolutionary ancient PGG1
strains. The remaining predominant SITs (SIT42 and SIT20
belonging to the LAM9 and LAM1 sublineages of LAM clade, and
SIT47 and SIT50 belonging to the H1 and H3 sublineages of
Haarlem clade) were characteristic of the evolutionary-recent
PGG2/3 subgroups. The last predominant spoligotype (SIT53)
also belonged to the evolutionary-recent T1 sublineage, nonethe-
less, the ‘‘T’’ family does not represent a genotypic lineage in a
strict evolutionary sense since it was defined by default to include
strains that could not be classified in one of the established lineages
with well-established phylogeographical specificity such as the
Haarlem, LAM, CAS, and EAI lineages [8].
Thus if one adds all the PGG1 isolates in Guinea-Bissau, i.e.,
AFRI n=195, EAI n=25, Beijing n=7, Manu n=4, CAS n=2,
and one unknown lineage pattern (SIT1200) that could be
nonetheless classified as PGG1, the total number of ancestral strains
in Guinea-Bissau amounts to 234/414 or 56.52% of all strains.
To get an indication of the distribution of the Guinea-Bissau
family in Africa, and in spite of the fact that the SITVIT2 is not
absolutely representative in terms of proportional representation,
we decided to compare all the data obtained in Guinea-Bissau,
and compared it to isolates in the SITVIT2 from various
subregions of Africa following United Nations geoscheme, i.e.,
Eastern Africa, Middle Africa, Northern Africa, Southern Africa,
and Western Africa (which included Guinea-Bissau). The results
obtained for a global collection of 11956 clinical isolates in the
database are summarized in Figure 1, and highlight major
differences in the population structure of circulating tubercle
bacilli in Africa. It should be noted that to facilitate comparison,
results were only tabulated for all major lineages with a cut-off at
3% (i.e., strains belonging to all minor lineages below the cut-off
3% are pooled together and shown as ‘‘Other’’). Furthermore, all
spoligotyping signatures that are not yet associated to a well-
defined genotypic lineage in SITVIT2 were designated as
‘‘Unknown’’.
As for other subregions, this distribution in Guinea-Bissau does
not take into account the minor lineages below the cut-off of 3%
that included Beijing, X, Manu and CAS lineages.
RFLP
Out of the 402 isolates investigated, 193 different RFLP
patterns were obtained, of which 268 (66.7%) isolates were
clustered into 61 RFLP-clusters, comprising 2–45 isolates per
cluster. The remaining 132 (32.8%) RFLP patterns were unique
i.e. the isolates did not cluster with other patient isolates. Of the
Guinea-Bissau Mycobacterium tuberculosis Complex
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(75.6%) isolates, and 121/209 (57.9%) of the non-M. africanum
isolates were clustered into 24 and 37 RFLP-clusters respectively.
Of those with an M. africanum spoligotype 125/193 had 5 bands or
less (median 5 bands) and 38/209 of the non-M. africanum isolates
had 5 bands or less (median 9 bands).
RD702
Of the 195 isolates with a M. africanum signature 192 isolates
were analyzed for RD702; they all showed a PCR product of
, 700 bp indicating that RD702 is absent in the Guinea-Bissau
family isolates.
Single-nucleotide polymorphism in the narGHJI operon
Twenty-eight Guinea-Bissau isolates, representing all five
biovars [4], were investigated. Six of the isolates were nitrate
reductase positive, while 22 were negative. The M. tuberculosis
H37Rv reference strain served as a control. All 28 isolates showed
a single PCR product with a size of approximately 155 bp. For all
but one of the Guinea-Bissau family strains, irrespective of nitrate
reductase activity, the subsequent digestion with Sau3AI, specif-
ically cutting at the GATC sequence, produced two bands (, 90
and , 70 bp) showing that these strains harbored the -215C
promoter SNP. For the M. tuberculosis H37Rv reference strain and
one Guinea-Bissau strain (nitrate positive) cleavage was not
Figure 1. Geographical distribution of spoligotyping-based genotypic lineages of Mycobacterium tuberculosis in various subregions
of Africa (n=11956 clinical isolates) in the SITVIT2 database.
doi:10.1371/journal.pone.0018601.g001
Guinea-Bissau Mycobacterium tuberculosis Complex
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bp.
Trends over time
The proportion of AFRI_1 significantly decreased over time
when the three studies A, B and C were compared (P-value
=0.048). Thus in study A 118 (52%) of 229 isolates were AFRI, in
study B 60 (44%) of 138 isolates were AFRI, and in study C 18
(38%) of 47 isolates were AFRI. The AFRI_3 isolate was found in
1996 (study B).
Discussion
The Guinea-Bissau family is a member of the M.
africanum West African 2 lineage Traditionally, M. africanum
strains were defined according to their phenotypic traits and
geographic origin, and were accordingly named West African
(subtype I) and East African (subtype II) M. africanum [4,18]. Based
on genetic definitions so called M. africanum subtype II strains are
now regarded as phenotypic variants of M. tuberculosis [19,20,21].
M. africanum subtype I (West African M. africanum) strains are
defined on the basis of particular genotypic characteristics that
place them in the M. tuberculosis complex phylogenetic tree
[2,19,22,23]. Thus, genomic deletions, or regions of difference
(RDs), can effectively distinguish them from M. tuberculosis and M.
bovis. Isolates of West African M. africanum lack RD9 and are
positive for RD12 [19,20]. We subsequently refer to M. africanum
subtype I as M. africanum. M. africanum strains can be further
subdivided into two main lineages, West African 1 and West
African 2 [12,20]. West African 1 isolates lack RD711, while West
African 2 isolates lack RD 7, 8, 10 and 702 [12,24]. By
spoligotyping M. africanum is defined by loss of spacers 8, 9 and
39. Three sublineages are defined based on finer differences:
AFRI_1 by loss of spacers 7–9, and 39, AFRI_2 by loss of spacers
8–12, 21–24, and 37–39, and AFRI_3 by loss of spacers 8–12, and
37–39. These subdivisions correspond to LSP-defined classifica-
tion as follows: AFRI_1 corresponds to West African 2, while
AFRI_2 and AFRI_3 collectively constitute the West African 1
lineages.
This study of M. tuberculosis complex isolates from Guinea-
Bissau, collected during two decades, shows that TB in Guinea-
Bissau is essentially caused by predominant genotypes character-
istic of the Western and Middle African region, with the highest
prevalence of M. africanum (AFRI_1/West African 2) in the whole
African continent. Forty-seven percent of all isolates were of what
we call the Guinea-Bissau family, a member of the M. africanum
AFRI_1/West African 2 lineage.
Thus, they have an AFRI_1 spoligotype pattern [1] (this study),
they have a distinct RFLP pattern with low numbers of IS6110
insertions [1] (this study) and they lack the four regions of
difference RD7, RD8, RD9 and RD10 [2], as well as RD701 [3]
and RD702 (this study). This profile classifies the Guinea-Bissau
family strains, irrespective of phenotypic biovar, as part of the M.
africanum West African 2 lineage [24] or the AFRI_1 sublineage
according to the spoligotyping nomenclature. This family shows
an extremely high phylogeographical specificity for Western
Africa, with Guinea-Bissau being the epicenter.
Other lineages. In addition to the AFRI isolates 25 isolates
were of the ‘‘ancient’’ EAI lineage, and the remaining strains were
‘‘modern’’ M. tuberculosis strains. These latter strains most likely
represent strain importation from countries where such strains
predominate. Only a few isolates were of the Beijing lineage,
which is relatively rare in Africa, except for parts of South Africa
[25].
Historically, Guinea-Bissau is a former colony of Portugal, a
country with a high incidence of TB caused by the classical human
M. tuberculosis type. Thus, contacts between the populations of
Guinea-Bissau and Portugal have probably been more numerous
than contacts between the populations of Guinea-Bissau and other
African countries. We therefore speculate that these M. tuberculosis
strains may have their origin from within Portugal [1]. Indeed,
some of the isolates had RFLP patterns that were identical to
isolates from Portuguese TB patients [1].
An interesting observation was the exclusive presence of an
EAI5 sublineage (SIT527) in Guinea-Bissau. LAM10-CAM strains
were found in a very low proportion, with only 2/414 (0.5%) of
such isolates, interestingly both strains belonged to LAM10-CAM
prototype SIT61. Yet they are predominant in Middle Africa and
Western Africa, with phylogeographical specificity of LAM10-
CAM for Cameroon and neighboring countries in West Africa
[8,26], and a recent study showed that LAM10-CAM prototype
SIT61 was also the most predominant spoligotype in Cotonou,
Benin [27].
Another interesting feature was the total absence of M. bovis in
our dataset. Similarly, the finding of four Manu strains in Guinea-
Bissau is noteworthy. The "Manu" lineage was initially described
as a new family from India in 2004 [28], and later similar strains in
small numbers were reported in a study from Madagascar [29].
Soon afterwards, it was tentatively subdivided into Manu-1
(deletion of spacer 34), Manu-2 (deletion of spacers 33–34) and
Manu-3 (deletion of spacers 34–36) sub-lineages, with the
suggestion that it could represent an ancestral clone of PGG1
strains [8]. More recently, Manu lineage strains were reported
from Saudi Arabia, [30] Tunisia [31], and Egypt [32]. In the latter
study, Manu lineage strains represented as high as 27% of all
isolates, with the new addition of SIT523 (all 43 spacers present)
designated as ‘‘Manu-ancestor’’ [32]. However, it was recently
suggested that some Manu strains may eventually correspond to a
‘‘mixed’’ pattern due to concomitant Beijing and Euro-American
lineage strains (the latter comprising H, LAM, X, and T lineages
in spoligotyping defined clades), a possibility that may be
investigated by RD105 analysis of Manu pattern isolates [33].
Phenotype and genotype
Although the M. africanum-specific deletions each have putative
biological consequence, they do not directly account for these
mentioned variable biochemical characteristics. However, geno-
mic variations other than the deletion of large sequence
polymorphisms (LSPs) may be relevant for the observed
phenotypic variability. Small polymorphisms, single nucleotide
polymporhisms (SNPs), gene rearrangements, or genomic regions
absent from H37Rv but present in M. africanum (duplications,
insertions) are overlooked when applying RD analysis. As a result,
phenotypic heterogeneity among M. africanum may be due to
unidentified genetic polymorphisms.
Classical M. bovis strains, in contrast to M. tuberculosis strains, are
naturally resistant to PZA and lack PZase activity. A point
mutation in the pncA gene has been thought to be the cause of the
defective PZase activity and PZA resistance in classical M. bovis
strains [34]. We have investigated isolates of the Guinea-Bissau
family (Study A), and found that irrespective of phenotypic PZase
activity, they all had the M. tuberculosis genotype in the pncA gene
[1] (data not shown). This was true also for isolates lacking PZase
activity, indicating that the variation in phenotypic PZase activity
is not due to a variation in the pncA gene.
The differential nitrate reductase (NO3) activity of M. tuberculosis
versus M. bovis has been reported to be due to a SNP in the
narGHJI operon promoter [13]. The Guinea-Bissau strains tested,
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as defined by the two-band pattern observed in PCR-RFLP. This
genotype is present in M. bovis and some ancestral M. tuberculosis
[35], and has been connected with a reduced nitrate reductase
production. Expression of narGHJI is typically induced under
anaerobic conditions, anaerobic nitrate reductase activity being
expressed in both -215T and -215C genotypes. However,
anaerobic nitrite reductase activity is considerably lower in M.
bovis, which carries the -215C genotype, compared to M.
tuberculosis. Diagnostic nitrate reductase activity is generally
measured as the rapid accumulation of nitrite by the bacilli within
two hours. M. bovis typically needs a longer time to accumulate
detectable amounts of nitrite from nitrate [13]. Thus, the variable
expression of nitrate reductase by M. africanum may be due to the
narrow time-detection limit of nitrite defined by the test used and
not a genotypic difference between individual M. africanum strains.
The differential expression of these biochemical traits is
therefore not related to any genes that have been reported to
differentiate between M. bovis and M. tuberculosis. Instead, we
hypothesize that Guinea-Bissau strains may more readily switch
genes on and off during its adaptation to hosts of different species
(and hence broaden their host tropism) [4].
Will the Guinea-Bissau family of strains disappear from
West Africa?
This analysis shows that there exists a clear gradient in the
African continent; M. africanum being predominant in Western and
Middle Africa, EAI and CAS in Northern and Eastern Africa,
Beijing and X essentially limited to Southern Africa, while LAM,
Haarlem, and T are distributed throughout.
During the 15-year period since isolates were first collected, the
proportion of isolates of the Guinea-Bissau family have diminished
over time. This is in agreement with trends in some other West
African countries, Cameroon [17] and Burkina Faso [36], where
the proportion of M. africanum isolates have drastically decreased
during the last decades. M. africanum appears at various frequencies
in West Africa. In Sierra Leone a recent study identified 23/97
(24%) isolates as M. africanum [37], which appears to be similar to
that reported from a study in 1992/1993 [18]. In The Gambia,
38% of isolates were M. africanum [38] and in Ghana 29% [39]. In
the 1970’s, most cases of TB in Cameroon were caused by M.
africanum [40], while three decades later only 9% of cases were
reported to be caused by M. africanum [17]. This change appears to
be due to the recent expansion of the so-called Cameroon family
of M. tuberculosis [17,26]. In Burkina Faso, M. africanum was not
detected in a recent survey [36] although M. africanum strains
(defined by phenotypic characteristics) were reported in about
20% of cases two decades earlier [36,41,42]. Interestingly, during
2007, two strains of the Cameroon family had found their way into
our setting.
The reason for the relative decline of M. africanum in West Africa
could be a lower transmission capacity or virulence. There is a
considerable uncertainty about the virulence of M. africanum.I n
studies from The Gambia [11,38,43,44] and Ghana [39] this issue
has been addressed. No difference in virulence, as assessed by the
severity of radiological presentation, was found between the West
African 1 and West African 2, and M. africanum was seen to closely
resemble M. tuberculosis in pathology [39]. The pathology in
patients with smear positive TB caused by M. africanum (West
African 2) were found to be as severe as that of M. tuberculosis
patients [44]. However, when comparing M. tuberculosis and M.
africanum (West African 2) the rate of progression to disease was
higher in household contacts of index patients with M. tuberculosis
compared to those with M. africanum infection [43]. Interestingly,
M. africanum elicited an attenuated T cell response to early secreted
antigenic targets in patients with TB and their household contacts
[11].
Another reason for the decline of M. africanum in West Africa
could be that certain ‘‘modern’’ lineages possess advantages in
their ability to disseminate within a community, in relation to
more ‘‘ancient’’ lineages such as M. africanum. Of particular interest
in this context is the appearance of Beijing isolates, as well as the
recent isolation of two strains of the Cameroon family in our study.
Beijing strains have recently been shown to have emerged and
rapidly expanded in South Africa [25].
In conclusion the Guinea-Bissau family of strains, irrespective of
phenotypic biovar, is part of the M. africanum West African 2
lineage, or the AFRI_1sublineage according to the spoligotyping
nomenclature. The variation of biochemical traits classically used
to differentiate M. tuberculosis from M. bovis is not related to any
genes so far investigated (narGHJI and pncA). The Guinea-Bissau
family shows an extremely high phylogeographical specificity for
Western Africa, with Guinea-Bissau being the epicenter. Trends
over time however indicate that this family of strains is waning in
most parts of Africa, including Guinea-Bissau.
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